Rapid test for dry eye disease will be available in US soon

Rapid Pathogen Screening Inc. announced it has received a Clinical Laboratory Improvement Amendments waiver from the U.S. Food and Drug Administration for InflammaDry.InflammaDry is a rapid, disposable, in-office test to aid in the diagnosis of dry eye disease, according to a company press release.

Full Story →